Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics Approach for the Improvement of COVID-19 Treatment

5 Mar 2021

Abstract excerpt

The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients’ outcomes with this complex disease; nevertheless, several disease-related issues must be carefully reviewed in the pharmacogenetic study of COVID-19 treatment. We aimed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics Pharmacokinetics and Efficacy
Share to Drug-Induced Hepatotoxicity and Protection
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33807592
DOI: 10.3390/v13030413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics Approach for the Improvement of COVID-19 TreatmentPMID 33807592Read ↗

Genetic Profiles in Pharmacogenes Indicate Personalized Drug Therapy for COVID-19Semantic proximity Read ↗

Pharmacogenomics to Drive COVID-19 Therapy for Best Outcome in a Low Resource SettingSemantic proximity Read ↗

Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 PatientsSemantic proximity Read ↗

Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.Semantic proximity Read ↗

Gene influencing in COVID-19 infection, disease severity and its PharmacotherapySemantic proximity Read ↗

Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screensSemantic proximity Read ↗

Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a genetic-based cautionary guide for treatment of COVID-19 symptomsSemantic proximity Read ↗

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.govSemantic proximity Read ↗

Exploration of interethnic variation in the ibuprofen metabolizing enzyme CYP2C9: a cautionary guide for treatment of COVID-19 symptomsSemantic proximity Read ↗

In-silico analysis of nsSNPs in human CYP3A4/5 and their effects on drug-enzymes interactions of FDA-approved COVID-19 antiviral drugs: A pharmacogenetic studySemantic proximity Read ↗

Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity Read ↗

Drug-utilisation Profiles and COVID-19: Retrospective Cohort Study in ItalySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.